CVI Investments, Inc. 13D and 13G filings for Virpax Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2022-02-14 3:23 pm Sale | 2021-12-31 | 13G | Virpax Pharmaceuticals, Inc. VRPX | CVI Investments, Inc. | 0 0.000% | -4,000 (Position Closed) | Filing |
| 2021-09-20 10:32 am Purchase | 2021-09-14 | 13G | Virpax Pharmaceuticals, Inc. VRPX | CVI Investments, Inc. | 4,000 8.500% | 4,000 (New Position) | Filing |